Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte

  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités

2 results

  • Topics : Urologic diseases
  • Topics : Urogenital surgery
Filter
Topic
  • Economics and public health (2)
  • Plus ...
    • Organisation of care (1)
    • Health economics (1)
  • Diagnostic and therapeutic techniques (2)
  • Plus ...
    • Surgical procedures (2)
    • Plus ...
      • Urogenital surgery (2)
  • Diseases and conditions (2)
  • Plus ...
    • Urologic diseases (2)
    • Plus ...
      • Urination disorders (2)
    • Genital diseases (2)
    • Plus ...
      • Male genital diseases (2)
      • Genital cancers (1)
Content type
  • Drugs, devices and medical acts (2)
  • Plus ...
    • Health technology assessment (2)
Manufacturer
  • inconnu (1)
  • industriels (1)
Language
  • Français (2)
Active substance
  • aluminium (1)
  • aspirine (1)
  • clopidogrel (1)
  • doxazosine (1)
  • lithium (1)
  • mannitol (1)
  • phosphate (1)
  • potassium (1)
  • silodosine (1)
  • tamsulosine (1)
 More filter Other Filter Icon
Search Export

Drugs, devices and medical acts - 2 results

  • Assessment of Clinical and Organisational Aspects of Robot-Assisted Surgery for Radical Prostatectomy - INAHTA Brief

    Health technology assessment - Posted on 22/12/2016
    Download document
    Add to my selection

  • Laser treatment of lower urinary tract symptoms associated with benign prostatic

    Health technology assessment - Posted on 12/12/2013
    Add to my selection

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
vCxuPyhFZ4pHdHDV